CohBar Inc.

0.41
0.00 (0.00%)
At close: Jan 23, 2025, 8:00 PM
undefined%
Bid n/a
Market Cap 1.19M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -4.37
PE Ratio (ttm) -0.09
Forward PE n/a
Analyst n/a
Ask n/a
Volume 172
Avg. Volume (20D) 2,994
Open 0.41
Previous Close 0.41
Day's Range 0.41 - 0.41
52-Week Range 0.00 - 1.01
Beta undefined

About CWBR

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its l...

[Show more]
Industry Biotechnology
Sector Healthcare
IPO Date Dec 15, 2017
Employees 9
Stock Exchange NASDAQ
Ticker Symbol CWBR
Website https://www.cohbar.com
news image

1 year ago · businesswire.com

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

MENLO PARK, Calif.--(BUSINESS WIRE)--On November 20, 2023, CohBar, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) of...

news image

1 year ago · businesswire.com

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of CohBar, Inc. (...

news image

1 year ago · headlinesoftoday.com

Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.

MILWAUKEE, May 24, 2023 /PRNewswire/ — Ademi LLP is investigating CohBar (NASDAQ: CWBR) for possible breaches of fiduciary duty and other violations of law in its transaction with Morphogenesis, Inc. ...

news image

1 year ago · investorplace.com

Why Is CohBar (CWBR) Stock Up 130% Today?

CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see ...

news image

1 year ago · businesswire.com

CWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of CohBar, Inc. (NASDAQ: CWBR) and Morphogenesis, Inc. is fair to CohBar shareholders. Hal...

Create Price Alert on CWBR

Your price alert will notify you when the stock price is above 0.41.

Add to Watchlist